Biopharma Insights
Bio-Rad Laboratories
Streamlining biopharmaceutical purification with continuous chromatography
Heidi Jones, market development manager, Chromatography, Bio-Rad Laboratories discusses streamlining biopharmaceutical purification with continuous chromatography.
3 Dec 2025
Solventum
Reimagining clarification in biopharmaceutical manufacturing
Elliott Zell, global new product marketing manager for Solventum Bioprocessing Filtration looks at reimagining clarification in biopharmaceutical manufacturing.
7 Oct 2025
VectorMine Shutterstock
Why the future of single-use bioprocessing depends on environmental accountability
Michael Franco, director of Global Biopharma Sales, PSG Biotech explores the question: "how do we maintain the benefits of single-use while reducing the environmental burden they create?"
21 Aug 2025
LectureLinx
When costing and compliance collide
Ellen Varelas, founder & CEO of LectureLinx, a global provider of innovative compliance technology and services solutions for the bio-pharmaceutical industry discusses the importance of compliance in the pharma industry.
7 Jul 2025
Rockwell Automation
Q&A: The role of MES in biopharma
Roger Gaemperle, industry strategy & marketing manager – consumer packaged goods & life science EMEA at Rockwell Automation discusses the role of MES in biopharma.
2 Jun 2025
Watson-Marlow
How is all single-use not created equal?
Ray Baldwin, business development manager, Watson-Marlow Fluid Technology Solutions (WMFTS) explains how all single-use is not created equal and how you can tell the difference.
7 Apr 2025
Nmblr
Collaborative strategy platform launches to empower biopharma teams
In a drug development landscape defined by shifting policies, geopolitical uncertainty, and increasing competitive pressure, a new collaborative strategy platform, Nmblr, has launched to empower teams to reach peak sales faster and with confidence.
12 Nov 2025
SGS
SGS announces webinar for pharma and biopharma professionals
SGS has announced its webinar, ‘USP665 in Practice: Addressing Industry Questions on Single-Use System Compliance’, taking place on 20th November 2025.
5 Nov 2025
Shutterstock Vector Stock Pro
"Industry faces talent crunch and regulatory strain"
Cytiva, a Danaher company, has launched its third Global Biopharma Index.
23 Oct 2025
Sponsored Content
White Raven sets new standards for achieving GMP certification
Download the Playbook to learn how White Raven reached GMP certification in just 18 months.
IMA Active
Q&A: The latest innovation in tablet press
Olivia Friett, editor of European Pharmaceutical Manufacturer, spoke to Luca Cavazzini, sales & marketing director at IMA Active, about the company’s newest developments.
12 Dec 2025
Astoriom
Why robust temperature control is essential to protect product integrity
Philip Bradley, general manager at Astoriom shares why robust temperature control is essential to protect product integrity, compliance, and patient safety.
12 Dec 2025
Protecting vaccine shipments in 2026: What the next era of Cold Chain looks like
Barbara Morgan, regional president Americas at Envirotainer explores what the next era of cold chain looks like.
10 Dec 2025
Pharmaceutical Insights + Pharmaceutical Logistics & Distribution Insights
SHL Medical
Making at-home lyophilised drug delivery possible
SHL Medical’s Reunite is showing that self-administering lyophilised drugs at home is finally within reach.
9 Dec 2025
Aragen
Q&A: Aragen shares 2026 predictions
European Pharmaceutical Manufacturer spoke to Ashu Tandon, CCO, Aragen at CPHI Frankfurt about their 2026 predictions for the company.
8 Dec 2025
Shutterstock - DIA TV
Q&A: Syngene at CPHI Frankfurt
At CPHI Frankfurt, we sat down with Peter Bains, MD & CEO of Syngene International, to discuss the company’s recent investments in peptides and antibody–drug conjugates (ADCs) and the broader evolution of integrated development in biologics.
5 Dec 2025
Sponsored Content
Stevanato Group
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00
Sponsored Content
White Raven sets new standards for achieving GMP certification
Download the Playbook to learn how White Raven reached GMP certification in just 18 months.
Sponsored Content
Stevanato Group
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00